ATAI Life Sciences
Mental Health Treatments
6 open rolesMental Health TreatmentsBerlin, Germany99 employees$387M raisedEst. 2018
About ATAI Life Sciences
- ATAI Life Sciences is a clinical-stage biopharmaceutical company focused on developing psychedelics, other hallucinogens, entactogens, and related drugs for the treatment of psychiatric conditions.
- Its mission is to pioneer effective mental health treatments to transform patient outcomes and address unmet needs.
ATAI Life Sciences is listed on Rocketlist with 6 active roles. The company is categorized as Mental Health Treatments in BioTech. ATAI Life Sciences is at Public stage, with a B2B business model, headquartered in Berlin, Germany. ATAI Life Sciences was founded in 2018 and has 99 employees. ATAI Life Sciences has raised $387M. Active roles are refreshed daily from public hiring sources.